(NASDAQ: IRTC) Irhythm Technologies's forecast annual revenue growth rate of 18.84% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Irhythm Technologies's revenue in 2026 is $702,573,000.On average, 18 Wall Street analysts forecast IRTC's revenue for 2026 to be $28,440,159,718, with the lowest IRTC revenue forecast at $26,964,845,160, and the highest IRTC revenue forecast at $29,742,135,286. On average, 15 Wall Street analysts forecast IRTC's revenue for 2027 to be $32,863,525,860, with the lowest IRTC revenue forecast at $31,023,490,603, and the highest IRTC revenue forecast at $34,571,140,439.
In 2028, IRTC is forecast to generate $38,534,095,028 in revenue, with the lowest revenue forecast at $36,600,946,448 and the highest revenue forecast at $40,112,833,035.